Harmonic Bionics, Inc.

AUSTIN, TX · Founded 2016 · Medtech · Acquired

Robotic exoskeleton system for shoulder and arm rehabilitation in stroke patients

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · harmonicbionics.com

Sector: Medtech
Headquarters: AUSTIN, TX
Founded: 2016
Latest Form D: $3M, Jun 2022
Total capital: $10.6M

Federal grants: $225K; 1 award · 2017; Rank in peer group#287 of 542
Private capital raised: $10.4M; 2 Form D · last Jun 2022; 52 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 5; 4 pending · first 2021; Rank in peer group#36 of 542

Capital timeline

Latest events

Jun 2022Private capital raisedForm D · SEC · 2nd filing$3M
Mar 2021Private capital raisedForm D · SEC · 1st filing$7.4M
Dec 2017Federal grantNSF · Phase I · SBIR Phase I: A Novel Bimanual Upper-body Exoskeleton for Stroke Therapy$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

39months

from Harmonic Bionics, Inc.’s first federal award to its first private round.

First federal award · Dec 2017: NSF · $225K
First Form D · Mar 2021: $7.4M · 1st Form D
Awards before first raise: 1 award

An association in public records, not a cause or a prediction.

Standing among 542 peers

Line = median

Medtech · Device

Federal grantsBelow median
Granted patents#36 · top 7%
Linked publications#8 · top 1%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

Youngmok YunResearcherExecutive Officer, DirectorLinked by 1 patent · $225K in grants as PI
Adam BermanDirectorNamed in SEC Form D filings
Ashish DeshpandeExecutive Officer, DirectorNamed in SEC Form D filings
Christopher PrenticeExecutive Officer, DirectorNamed in SEC Form D filings
Phil YoonDirectorNamed in SEC Form D filings

What it has protected

USPTO · 5 granted of 9

Jul 22, 2025GrantedUpper Body Human To Machine InterfaceUSPTOUS 12,364,640
Nov 21, 2023GrantedActuator For Physical TherapyUSPTOUS 11,819,467
Apr 20, 2023PendingCompliant Mechanism for Improving Axial Load Sensing in Robotic ActuatorsUSPTOApplication 18067141

Show all 9 patent records

Upper Body Human To Machine InterfaceJul 22, 2025 · US 12,364,640Granted
Actuator For Physical TherapyNov 21, 2023 · US 11,819,467Granted
Compliant Mechanism for Improving Axial Load Sensing in Robotic ActuatorsApr 20, 2023 · Application 18067141Pending
Compliant Mechanism for Improving Axial Load Sensing in Robotic ActuatorsJan 3, 2023 · US 11,541,530Granted
Shield BoardNov 1, 2022 · US 11,487,692Granted
Actuator For Physical TherapyOct 19, 2021 · US 11,147,731Granted
Compliant Mechanism For Improving Axial Load Sensing In Robotic ActuatorsApplication PCTUS2022043930Pending
Robotic Joint Including A Remote Center Of Motion MechanismApplication PCTUS2023077716Pending
Systems And Methods For Controlling Robotic ManipulatorsApplication PCTUS2024023289Pending

Recent research by its founders

Improvement of hand functions of spinal cord injury patients with electromyography-driven hand exoskeleton: A feasibility study202015 cites
Abstract TP184: Upper-body Exoskeleton Assisted Stroke Rehabilitation Therapy in Complex Multi-joint Movements20190 cites
Maestro: An EMG-driven assistive hand exoskeleton for spinal cord injury patients201791 cites

Liberate Medical LLCSimilar federal contract value in Medtech · null in contracts
Anuncia Medical, Inc.Similar federal contract value in Medtech · null in contracts
Bloomlife, Inc.Similar federal contract value in Medtech · null in contracts
UCHU BIOSENSORS, INC.Similar federal contract value in Medtech · null in contracts
RCE TECHNOLOGIES, INC.Similar federal contract value in Medtech · null in contracts
COLOWRAP, LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.